Inventor · disambiguated record
Methvin Isaac
Also filed as: ISAAC METHVIN · ISAAC METHVIN BENJAMIN
36 granted patents·58 pending applications·480 citations·filing 1999–2024
97Inventor score
Files withASTRAZENECA AB41NPS PHARMA INC14ONTARIO INSTITUTE FOR CANCER RES OICR9NPS ALLELIX CORP5PROPELLON THERAPEUTICS INC4
Top patents by PatentIndex Score
94 records- 0198US6660753B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2002·Granted Dec 9, 2003·160 cites·58 claims
- 0296US7112595B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2003·Granted Sep 26, 2006·92 cites·23 claims
- 0393US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 0493US7485722B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2007·Granted Feb 3, 2009·29 cites·13 claims
- 0588US7799792B2Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841ASTRAZENECA AB·Filed 2008·Granted Sep 21, 2010·11 cites·14 claims
- 0687US7960422B2Pharmaceutically active compounds containing tetrazolyl and triazolyl ringsASTRAZENECA AB·Filed 2008·Granted Jun 14, 2011·11 cites·2 claims
- 0786US11505539B2Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degradersONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Nov 22, 2022·3 cites·16 claims
- 0886US7868008B2Substituted isoindolones and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Jan 11, 2011·11 cites·4 claims
- 0985US7476684B2Compounds for the treatment of neurological, psychiatric or pain disordersASTRAZENECA AB·Filed 2006·Granted Jan 13, 2009·11 cites·5 claims
- 1083US7074809B2CompoundsNPS PHARMA INC·Filed 2003·Granted Jul 11, 2006·23 cites·12 claims
- 1182US7807706B2Metabotropic glutamate-receptor-potentiating isoindolonesASTRAZENECA AB·Filed 2006·Granted Oct 5, 2010·6 cites·9 claims
- 1282US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 1381US8377940B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·4 cites·13 claims
- 1481US7968570B2Isoindolone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2005·Granted Jun 28, 2011·6 cites·4 claims
- 1581US6897215B1Compounds having 5-HT6 receptor antagonist activityNPS ALLELIX CORP·Filed 2000·Granted May 24, 2005·11 cites·23 claims
- 1680US11518764B2Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interactionONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2019·Granted Dec 6, 2022·3 cites·18 claims
- 1779US11174250B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted Nov 16, 2021·3 cites·23 claims
- 1876US6716837B1Heterocyclic compounds for the treatment of migraineNPS ALLELIX BIOPHARMACEUTICALS·Filed 2000·Granted Apr 6, 2004·13 cites·20 claims
- 1975US7772235B2mGluR5 modulatorsASTRAZENECA AB·Filed 2007·Granted Aug 10, 2010·2 cites·6 claims
- 2074US7678796B2MGluR5 modulators IASTRAZENECA AB·Filed 2007·Granted Mar 16, 2010·3 cites·21 claims
- 2172US7576077B2Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 2271US7935703B2Piperazines and piperidines as Mglur5 potentiatorsASTRAZENECA AB·Filed 2007·Granted May 3, 2011·1 cites·2 claims
- 2368US11319299B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 2468US6166072AAmino acid derivativesALLELIX NEUROSCIENCE INC·Filed 1999·Granted Dec 26, 2000·12 cites·25 claims
- 2562US8377939B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·0 cites·4 claims
- 2662US2007293545A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2762US2008015204A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2862US2008045571A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2962US2008015234A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3062US2025154140A1Isoquinoline derivatives as inhibitors of bax and/or bak, compositions and uses thereofSUNNYBROOK RES INST·Filed 2023·Application pending·0 cites
- 3161US12264147B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·2 claims
- 3261US2024279226A1Ergoline-derived agonists of the 5-ht2a receptorDIAMOND THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3360US7790717B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2009·Granted Sep 7, 2010·0 cites·2 claims
- 3458US2024182480A15-ht2a and/or 5-ht2c receptor agonistsDIAMOND THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3557US2010280082A1Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as PotentiatorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 3657US2007179188A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 3756US6380242B1N-alkylamino-indoles for the treatment of migraineNPS ALLELIX CORP·Filed 1999·Granted Apr 30, 2002·11 cites·8 claims
- 3856US2024343704A1Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 3955US11192880B2Quinolone compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degradersONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Dec 7, 2021·0 cites·11 claims
- 4055US2024425479A1Halo-substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 4154US2024317723A1Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 4253US2007270469A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 4353US2024092763A1Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 4453US2007270468A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 4553US2024025887A1Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 4652US2007032469A1Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulatorsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 4752US2008312246A1Substituted Piperazines as Metabotropic Glutamate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4852US2008318999A1Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor ModulatorsISAAC METHVIN·Filed 2006·Application pending·0 cites
- 4952US2008312240A1Bicyclic Piperazines as Metabotropic Glutatmate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 5052US2007037820A1Substituted piperazines as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 94 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →